Van't Veer: I like fairy tales, but about the genes, are they really so promising? Can we solve a problem with genes? In 20 or 30 years? Is that a realistic way to look at weight? Or is it just a way to postpone the problem?
Rosser: I raised the issue; this was a promise from the head of the Human Genome Project, so obviously he is biased. But I guess there may be ways of dealing with this issue down the road that may be very powerful. I do not think we should write it off. And more and more governments in more and more countries are becoming concerned about this problem. So I think there are going to be more options to tackle this problem before an imaginary silver bullet comes.
Helman: When you look at all these community-based studies there is an optimum size. I know there have been a number of studies in which they have taken a small town.
But my question to Frans Kok is this: what is optimal?
Kok: I may not be the one to answer this question. I did not look at the specifics of the intervention strategies so much.
Brug: This is a really interesting issue; we had this discussion related to a PhD study that was presented a couple of months ago; what is indeed a community? Our neighbourhoods communities nowadays, with all these people moving in or moving out, and different cultures together, can you really do community-based interventions in circumstances that are not really communities? We may have to look for other entities that are more like communities. Maybe school-based interventions? Or worksite interventions. These may reflect communities better than neighbourhoods nowadays.
Green: I think Brug is exactly right on community interventions. We have to think about manageable opportunities to intervene in schools and worksites; neighbourhoods do not necessarily have the required cohesion. Maybe we have to intervene on state or regional level. But one of the reasons that big community trials have struggled to show significant effects, (I am in the scientific advisory committee of the Minnesota Heart Health Study), it is virtually impossible to outrun the control y. and the challenge is what are the alternatives to the randomized or quasiexperimental community projects. I think that what really made the difference in California and Massachussets, the two states that made real progression in the rate of decline of smoking, is that they installed very good surveillance methods. So my advice to the nutrition community is that you keep the surveillance systems in place. Monitor what is happening in the country. Then you are able to track the group differences. Maybe it does not call for randomized controlled trials, it calls for natural experiments.
Brug: Additionally to what Green said there is another problem of randomized controlled trials in communitybased interventions; because community-based interventions need to be bottom-up, people need to develop the interventions themselves; it hardly possible to randomize communities and then tell them: now you have to develop your own intervention. I truly believe in RCT or wellcontrolled situations; but I do think we have to keep an open mind to noncontrollable situations, and then also except non-RCT to evaluate those interventions. Otherwise we will always restrict ourselves to individual approaches in preventive interventions.
Koelen: The problem in community-based health promotion is generally we draw a sample out of the population; this may be a random sample of people living in an area, but when they come up from the community, they are not focussing on the whole population where the random sample is taken from. So we draw conclusions on a population level whereas the intervention actually was focussing on part of the population.
Rosser: About the issue of community size. In the paper that I had in the previous Heelsum meeting I talked about a project we did in a Canadian community of about 15 000 people; it was an intervention on how to reduce the use of antibiotics. Which is maybe equally as hard as dietary interventions. It worked quite well, it was effective, because of the size of the community we could go to all the right agencies and make sure they were involved: the mayor, the schools, the pharmacies, the hospitals. This changed the patterns; maybe even with the doctors. So that was an ideal setting; this town was somewhat isolated; it was 30 km from the next town.
Truswell: Caroline van Wayenburg seemed to end her paper with the question 'Should not undernutrition be covered separately, regardless of what may be the cause?' My answer would be that indeed it should be covered separately. As the outcomes are worse if you have got disease X plus undernutrition than just disease X on its own.
Mathus-Vliegen:
We did a study on undernutrition, and found that 75% of the patients in the surgical ward and 46% of the patients in the internal ward, and about 38% of patients in the geriatric ward were underfed. These patients come from the GP, so it is very strange that in the literature you cannot find good data on those patients.
Van Binsbergen: They come from the GP, and go back to the GP in an even worse state. I think it is good to mark it in your electronic dossier as a separate diagnosis.
Mathus-Vliegen: Just as Helman proposed to do the BMI part, also for underweight.
Van Weel: I do not think you should overestimate this. Because at this moment it is possible to do it; it is completely feasible within the ICPC to code different conditions that belong to the same episode. The observation is that underweight is not a stand alone problem, like overweight is. Underweight is a code problem. What the Amsterdam database shows is that even if you are liberal in coding, the number of underweight codes are fairly limited. So the majority of these people will have chronic diseases that only enter into the phase of weight loss when they are entering a nursing home or when they require hospital interventions.
